bimatoprost and travoprost/timolol fixed combination in glaucoma

bimatoprost and travoprost/timolol fixed combination in glaucoma - bimatoprost and travoprost/timolol fixed combination in glaucoma

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007235

Enrollment

Registered

2013-02-14

Start date

2011-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

bimatostost travoprost/timolol fixed combination

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: primary open-angle glaucoma or normal-tension glaucoma

Exclusion criteria

Exclusion criteria: Patients with any secondary factors that might induce glaucoma such as uveitis, and lens exfoliation in even one eye were excluded. Also, patients were excluded if they had any intraocular surgery including laser therapy or had any corneal condition preventing reliable Goldmann applanation tonometry such as pterygium.

Design outcomes

Primary

Measure	Time frame
efficacy and safety	—

Countries

Japan

Contacts

Public ContactAkira Sawada

Gifu University Graduate School of Medicine Ophthalmology

sawadaa-gif@umin.ac.jp058-230-6000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026